Testing a new imaging tool during prostate removal surgery
Part of Cancer, Kidney & urinary clinical trials.
This study tests if a special microscope called confocal laser endomicroscopy can help doctors check for leftover cancer cells faster during prostate removal surgery. It is for patients with intermediate or high-risk prostate cancer who are scheduled for robot-assisted prostate removal and have not had prior treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have intermediate or high-risk prostate cancer
- You are scheduled for robot-assisted prostate removal surgery
- You have not yet received any treatment for your prostate cancer
- You are 18 years old or older
- You can understand and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special microscope can help surgeons see cancer margins (edges) during prostate removal surgery to make sure all cancer is removed. It may help surgeons make real-time decisions about how much tissue to remove.
This study tests a new imaging technology during prostate cancer surgery to help surgeons see cancer edges more clearly in real time. The goal is to make sure all cancer is removed while protecting nearby healthy tissue.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial uses advanced MRI scans and detailed tissue analysis to better detect prostate cancer. It is for people with confirmed prostate cancer who are already scheduled for prostate removal surgery.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.